Lv1
10 积分 2025-03-05 加入
Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate Immunotherapy
19天前
已完结
Mitochondrial Disruption Nanosystem Simultaneously Depressed Programmed Death Ligand-1 and Transforming Growth Factor-β to Overcome Photodynamic Immunotherapy Resistance
22天前
已完结
Mitochondria-targeted carbon monoxide delivery nanoplatform for enhanced cancer immunotherapy through metabolic-immune reprogramming
22天前
已完结
A Hybrid Nanoadjuvant Simultaneously Depresses PD‐L1/TGF‐β1 and Activates cGAS‐STING Pathway to Overcome Radio‐Immunotherapy Resistance
22天前
已完结
Tropomyosin-1 positively regulates TGF-β/Smad3 signaling through STUB1 in arecoline-induced oral submucosal fibrosis
1个月前
已完结
Mitochondrial DNA in atherosclerosis: Mechanisms, biomarker potential, and therapeutic perspectives
3个月前
已完结
Sophora Compounds against Non-small Cell Lung Cancer: Research Status and Mechanisms
5个月前
已完结
Targeting a key FAK-tor: the therapeutic potential of combining focal adhesion kinase (FAK) inhibitors and chemotherapy for chemoresistant non-small cell lung cancer
5个月前
已完结
Non-small-cell lung cancer
5个月前
已完结
Wnt signaling in triple-negative breast cancers: Its roles in molecular subtyping and cancer cell stemness and its crosstalk with non-coding RNAs
5个月前
已完结